IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALBERICI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.801
AS - Asia 3.435
EU - Europa 2.007
SA - Sud America 807
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 90
OC - Oceania 12
Totale 11.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.640
SG - Singapore 1.232
CN - Cina 784
BR - Brasile 674
IT - Italia 613
HK - Hong Kong 471
VN - Vietnam 289
DE - Germania 239
UA - Ucraina 236
BD - Bangladesh 231
GB - Regno Unito 185
RU - Federazione Russa 150
FR - Francia 146
TR - Turchia 140
FI - Finlandia 111
CA - Canada 82
IE - Irlanda 80
IN - India 79
PL - Polonia 60
AR - Argentina 56
NL - Olanda 40
MX - Messico 39
IQ - Iraq 34
JP - Giappone 31
ID - Indonesia 26
ZA - Sudafrica 24
AT - Austria 23
SA - Arabia Saudita 20
SE - Svezia 19
CO - Colombia 18
DZ - Algeria 18
EC - Ecuador 18
CZ - Repubblica Ceca 16
EG - Egitto 14
ES - Italia 14
MA - Marocco 14
PY - Paraguay 13
BE - Belgio 10
LT - Lituania 10
PK - Pakistan 10
UZ - Uzbekistan 10
CL - Cile 9
EU - Europa 9
JM - Giamaica 9
AU - Australia 8
CR - Costa Rica 7
IR - Iran 7
MY - Malesia 7
TH - Thailandia 7
CH - Svizzera 6
IL - Israele 6
KZ - Kazakistan 6
PE - Perù 6
PT - Portogallo 6
RO - Romania 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
KE - Kenya 5
KG - Kirghizistan 5
PH - Filippine 5
RS - Serbia 5
UY - Uruguay 5
DK - Danimarca 4
HU - Ungheria 4
JO - Giordania 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
GY - Guiana 3
LB - Libano 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
SC - Seychelles 3
VE - Venezuela 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LU - Lussemburgo 2
MM - Myanmar 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
GE - Georgia 1
Totale 11.149
Salva come PNG Salva come JPEG
Città #
Singapore 602
Ashburn 482
Hong Kong 468
Fairfield 420
San Jose 309
The Dalles 241
Woodbridge 226
Beijing 220
Houston 193
Jacksonville 177
Seattle 170
Wilmington 156
Cambridge 152
New York 147
Princeton 145
Los Angeles 124
Lauterbourg 119
Istanbul 97
Ho Chi Minh City 96
Dallas 89
Helsinki 84
Columbus 79
Dublin 78
Council Bluffs 75
Chandler 72
Hanoi 72
Ann Arbor 70
São Paulo 62
Chicago 54
Munich 53
Warsaw 52
Buffalo 51
Milan 49
Moscow 48
Brescia 47
Santa Clara 42
San Diego 41
Redondo Beach 40
Des Moines 33
Rome 33
Shanghai 33
Frankfurt am Main 31
Nuremberg 29
London 28
Toronto 25
Montreal 23
Orem 23
Chennai 22
San Francisco 22
Tokyo 22
Turku 21
Romola 20
Denver 19
Rio de Janeiro 17
Florence 16
Meram 16
Atlanta 14
Bologna 14
Brooklyn 14
Mexico City 14
Tianjin 14
Brno 13
Düsseldorf 13
Phoenix 13
Algiers 12
Belo Horizonte 12
Brasília 12
Dhaka 12
Las Vegas 12
Baghdad 11
Curitiba 11
Haiphong 11
Kocaeli 11
Naples 11
Boston 10
Brussels 10
Changsha 10
Jinan 10
Philadelphia 10
Stockholm 10
Washington 10
Amsterdam 9
Campinas 9
Quito 9
Vienna 9
Boardman 8
Buenos Aires 8
Goiânia 8
Jeddah 8
Johannesburg 8
Miano 8
Nanjing 8
Tashkent 8
Cape Town 7
Charlotte 7
Da Nang 7
Guangzhou 7
Hortolândia 7
Manchester 7
Mumbai 7
Totale 6.578
Salva come PNG Salva come JPEG
Nome #
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis 177
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 174
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): A phase III, randomized, multicentre trial of the italian oncology group for clinical research (GOIRC) 161
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 154
Genetics of ANCA-Associated Vasculitis 153
Nonlupus Full House Nephropathy 148
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 139
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response 136
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 133
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia 132
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 129
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience 129
Sustained post-rituximab B cell depletion is common in ANCA-associated Vasculitis and affected by sex and renal function 127
A cross-sectional study of the Birmingham vasculitis activity score version 3 in systemic vasculitis 127
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 124
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 123
Pneumocystis Jirevocii and SARS-CoV-2 co-infection: A common feature in transplant recipients? 123
[Glomerulonefriti da tossici e farmaci] 119
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 118
[Infection-related glomerulonephritis: the new face of an old disease] 118
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 115
Chronically administered immunotherapy with low-dose IL-2 and IFN-α in metastatic renal cell carcinoma: A feasible option for patients with a good prognostic profile 111
Update on ANCA-associated vasculitis: from biomarkers to therapy 109
Chronic periaortitis with thoracic aorta and epiaortic artery involvement: A systemic large vessel vasculitis? 108
[Peritoneal dialysis: what have we learned from the Covid-19 pandemic?] 108
PTPN22 R620W polymorphism in the ANCA-associated vasculitides 107
[Managing patients in dialysis and with kidney transplant infected with Covid-19] 107
Avacopan for the treatment of ANCA-associated vasculitis 107
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype 106
[The complex etiopathogenesis of focal segmental glomerulosclerosis] 105
The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort 104
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series 103
Impact of rituximab trials on the treatment of ANCA-associated vasculitis 103
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC) 102
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: An open-label randomised controlled trial 102
[ADPKD and intracranial aneurysms: indications for screening, follow-up and clinical management] 100
Orofacial granulomatosis treated with low-level laser therapy: A case report 99
IgG4 immune response in Churg-Strauss syndrome 99
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease 99
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 98
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving 98
Lupus nephritis and B-cell targeting therapy 98
Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation 98
The role of analytical methods for the determination of trace elements in environmental biomonitors 98
Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index 98
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis 97
Prevention of arterial thrombosis recurrence in anti-phospholipid syndrome: are anti-platelets the answer? 97
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis 97
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-α in patients with renal cell carcinoma 97
FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome 95
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 94
Peripheral inflammatory arthritis in patients with chronic periaortitis: Report of five cases and review of the literature 94
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial 93
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study. 92
Lessons From the Clinic: ADPKD Genetic Test Unraveling Severe Phenotype, Intrafamilial Variability, and New, Rare Causing Genotype 91
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) 90
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 89
Hemodialysis techniques and outcomes in patients with COVID-19: The Brescia experience 88
Genetics of ANCA-associated vasculitides: HLA and beyond 88
Chronic periaortitis associated with membranous nephropathy: Clues to common pathogenetic mechanisms 88
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 88
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 88
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 87
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis 87
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry 87
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 86
Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD 85
The Authors Reply 83
Association of a polymorphism of the Fc gamma-receptor 2A (FCGR2A) gene with chronic periaortitis 81
FCGR3B polymorphism predicts relapse risk in eosinophilic granulomatosis with polyangiitis 81
[State of art and new perspectives in the induction regimen of ANCA-associated vasculitis with renal involvement: from histopathology to therapy] 81
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy 79
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 79
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies 78
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 78
Correspondence on 'Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 78
Treatment of secondary hyperparathyroidism in hemodialysis patients: a comparison between two Italian centers to evaluate real-world guideline implementation 77
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study 75
Clinical Significance of the Cystic Phenotype in Alport Syndrome 75
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 74
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 74
Rituximab in Membranous Nephropathy 74
[Anti-SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases. Recommendations of the Italian Society on Nephrology's Working Group on Renal Immunopathology (Vaccine Task Force)] 74
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 72
Treatment goals in ANCA-associated vasculitis: defining success in a new era 71
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? 71
Variable Expressivity of HNF1B Nephropathy From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease 71
Peritoneal dialysis discontinuation: to the root of the problem 69
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab 69
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia 68
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 67
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study 66
Galileo—an Artificial Intelligence tool for evaluating pre-implantation kidney biopsies 66
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 65
Editorial: “Toward Precision Medicine in Vasculitis” 65
The ideal marker for measuring GFR: what are we looking for? 65
Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study 65
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis 61
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases 60
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 60
Totale 9.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022556 0 104 22 18 2 64 28 36 37 58 37 150
2022/2023373 83 2 7 7 20 114 0 30 48 2 28 32
2023/2024811 32 30 29 63 53 111 28 34 236 11 26 158
2024/20251.998 8 26 42 236 150 153 199 85 209 277 397 216
2025/20264.907 338 603 412 743 387 273 599 213 306 486 340 207
2026/2027436 290 146 0 0 0 0 0 0 0 0 0 0
Totale 11.319